Clinical Trial Update: Oral Progesterone for Prevention of Miscarriage in Threatened Abortion [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating oral progesterone for the prevention of miscarriage in threatened abortion has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Threatened Abortion

Drugs mentioned

• Oral progesterone (progesterone)

Snippet

Sponsor: Chulalongkorn University | Conditions: Threatened Abortion | Phase 4 | Status: COMPLETED